Jiangsu Walvax Biotech Co.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Jiangsu Walvax Biotech Co.
Study: FDA Data Shows Endoscope-Related Adverse Events Continue To Rise
A new review of adverse event data found reports tied to each of six endoscope categories rose significantly between 2014 and 2021. For gastroscopes, the rise was an eye-popping 8,630%.
Boston Scientific’s Single-Use Exalt-B Bronchoscope To Compete With Ambu’s aScope
Boston Scientific has received 510(k) clearance, launching it into a $1bn market where single-use scopes are increasingly recommended to prevent spread of infections.
FDA Recommends Broader Use Of Single-Use Bronchoscopes
The single-use scopes should be used in lieu of reprocessed devices when a significant infection risk exists, the US agency says.
Signs Of R&D Progress For GSK, Though China Overhang Remains
With four new drug approvals notched under its belt in four months, GlaxoSmithKline had several potential growth drivers to highlight during its third quarter earnings call, helping to deflect attention away from the bribery scandal in China.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice